Zenas BioPharma Announces Dosing of First Patient in Phase III Clinical Trial of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD).

Zenas BioPharma Announces Dosing of First Patient in Phase III Clinical Trial of Obexelimab for the Treatment of Immunoglobulin G4-Related Disease (IgG4-RD).

Global Phase III INDIGO study will evaluate the efficacy and safety of obexelimab in patients with IgG4-RD, a chronic and severe fibroinflammatory disease that typically affects multiple organs IgG4-RD is …

Read more

Doctors advocate wearing masks voluntarily after the corona pandemic

BERLIN Frank Ulrich Montgomery, Chairman of the Board of the World Medical Association, also believes that wearing masks in certain situations makes sense. “Relaxation doesn’t mean that you can let …

Read more